510(k) Report

510(k) · Cleared

Cleared

CML 1000

K051437510(k) TraditionalCleared Aug 3, 200563-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Icu Medical, Inc. · FPA Set, Administration, Intravascular

Cleared on Aug 3, 2005 as substantially equivalent to K970855 (Icu Medical, Inc., 1997) after a 63-day review. Its family tree reaches back 1 generation to 1997. 16 later devices descend from it.

Decided
Aug 3, 2005
Review
63 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K970855 (1997). 16 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared2011: 1 descendant cleared2023: 3 descendants cleared2012: 1 descendant cleared2007: 1 descendant cleared2009: 2 descendants cleared2010: 1 descendant cleared2014: 1 descendant cleared2017: 1 descendant cleared2022: 1 descendant cleared2024: 1 descendant cleared2025: 2 descendants clearedK970855 · Clave Connector · Icu Medical, Inc. · 1997 · recalled1995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 3 descendants3 generations forward: 2 descendants4 generations forward: 2 descendants5 generations forward: 1 descendant6 generations forward: 1 descendant7 generations forward: 2 descendants8 generations forward: 1 descendant9 generations forward: 2 descendants K970855 · Clave Connector · Icu Medical, Inc. · 1997 · recalled0+5
  1. Root · 1 generation backK970855 Clave ConnectorIcu Medical, Inc. · 1997 · Recalled
  2. This deviceK051437 CML 1000Icu Medical, Inc. · 2005
  3. Descendant · cites it directly · 14 of its ownK053049 Alaris Safety Male LuerCardinal Health, Alaris Products · 2006 · Recalled
  4. Descendant · 2 generations on · 11 of its ownK071108 Texium SyringeCardinal Health, Alaris Products · 2007 · Recalled
  5. Descendant · 3 generations on · 9 of its ownK083152 Equashield SystemPlastmed, Ltd. · 2009
  6. Descendant · 4 generations on · 8 of its ownK091389 Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009
  7. Descendant · 4 generations on · 7 of its ownK101940 Equashield System Protective PlusEquashield Medical, Ltd. · 2010

Showing 5 of 16 descendants. See all descendants

Descendants cleared per year

2006: 12007: 12009: 22010: 12011: 12012: 12014: 12017: 12022: 12023: 32024: 12025: 2
2006high 3 (2023) · low 0 (2008)2026

Most influential descendants

Showing 5 of 16 · See all
  • K053049Alaris Safety Male LuerCardinal Health, Alaris Products · 2006 · cites it directly14descendants
  • K071108Texium SyringeCardinal Health, Alaris Products · 2007 · 2 generations on11descendants
  • K083152Equashield SystemPlastmed, Ltd. · 2009 · 3 generations on9descendants
  • K091389Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009 · 4 generations on8descendants
  • K101940Equashield System Protective PlusEquashield Medical, Ltd. · 2010 · 4 generations on7descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K970855Clave ConnectorIcu Medical, Inc.199752
0 (this device)K051437CML 1000Icu Medical, Inc.2005—
+1K053049Alaris Safety Male LuerCardinal Health, Alaris Products20063
+2K071108Texium SyringeCardinal Health, Alaris Products20071
+3K083152Equashield SystemPlastmed, Ltd.2009—
+4K091389Equalshield Luer Lock Connector PairPlastmed, Ltd.2009—
+4K101940Equashield System Protective PlusEquashield Medical, Ltd.2010—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200710
200920
201010
201110
201210
201410
201710
202210
202330
202410
202520
FIG. 1 — Lineage of K051437, 1997–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K970855Clave Connector
Summary page 1
…ration set (21 CFR 880.5440) §807.92(a)(3) Legally Marketed Substantially Equivalent Device: Clave Connector K970855 §807.92(a)(4) Description of Device: The Closed Male Luer is a normally closed two-…
Icu Medical, Inc.199752

Also cleared against K970855: 14 other devices →

What descends from it? (16)

See all 16

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K053049Alaris Safety Male LuerCardinal Health, Alaris Products200614
K112636Cytoguard (TM) Closed Luer ConnectorB.Braun Medical, Inc.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K053049 (Cardinal Health, Alaris Products, 2006) has gone furthest, with 14 descendants of its own.
  • 14 other devices also cite its predicate K970855.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The CML, is a single use, sterile, non-pyrogenic, swab-able, bi-directional valve device intended for use as an accessory to intravascular administration set. The CML provides access for the administration of fluids from a container to a patient's vascular system through the administration needle or catheter (which is inserted into the vein or artery).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051437: CML 1000.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051437

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026